Nanosynex
Antimicrobial Susceptibility Test
Active
Seed
Startup
Tel Aviv-Yafo
Founded 2017-02
Nanosynex is developing solutions designed to improve testing quality and reduce healthcare costs by accelerating diagnostic processes. Nanosynex is focused on the development and commercialization of an innovative antimicrobial susceptibility test (AST). The technology is based on a purely phenotypic approach and uses a microfluidic disposable test cartrid…
SectorHealth Tech & Life Sciences
StageSeed
Total raised$6.3M
Employees8
Founded2017-02
HQTel Aviv-Yafo
Crunchbasenanosynex
Patents1
Confidence100
Sectors
Health Tech & Life SciencesDigital HealthcareDigital Medical DiagnosticsMedical Decision Support
Technology
BiologicalsPlatforms & InterfacesSoftware
Target customers
Healthcare & Life SciencesHealthcareLaboratoriesProviders